Appointments

Glaxosmithkline PLC
Position: NED
Holding Balance: 102,616 (0.0000%)
Appointed in 2015

Deals on 28 April 2021

DeclaredDealtTypeEPICCompanyDirectorPosSharesPriceValueCur. price% GainGain
28/04/2128/04/21BUYGSKGlaxosmithkline PLCManvinder Singh BangaNED676£13.40£9,0581,388.20p3.60£326.23

All Deals

DeclaredDealtTypeEPICCompanyDirectorPosSharesPriceValueCur. price% GainGain
28/04/2128/04/21BUYGSKGlaxosmithkline PLCManvinder Singh BangaNED676£13.40£9,0581,388.20p3.60£326.23
04/02/2103/02/21BUYGSKGlaxosmithkline PLCManvinder Singh BangaNED666£13.61£9,0641,388.20p2.00£181.41
30/12/2030/12/20BUYGSKGlaxosmithkline PLCManvinder Singh BangaNED36,600£13.76£503,4481,388.20p0.92£4,633.20
28/10/2028/10/20BUYGSKGlaxosmithkline PLCManvinder Singh BangaNED671£13.50£9,0591,388.20p2.83£255.82
29/07/2029/07/20BUYGSKGlaxosmithkline PLCManvinder Singh BangaNED570£15.89£9,0571,388.20p-12.64-£1,144.26
04/05/2029/04/20BUYGSKGlaxosmithkline PLCManvinder Singh BangaNED646£16.93£10,9371,388.20p-18.00-£1,969.23
05/02/2005/02/20BUYGSKGlaxosmithkline PLCManvinder Singh BangaNED399£18.00£7,1821,388.20p-22.88-£1,643.08
30/10/1930/10/19BUYGSKGlaxosmithkline PLCManvinder Singh BangaNED417£17.25£7,1931,388.20p-19.52-£1,404.21
24/07/1924/07/19BUYGSKGlaxosmithkline PLCManvinder Singh BangaNED548£16.54£9,0641,388.20p-16.07-£1,456.66
01/05/1901/05/19BUYGSKGlaxosmithkline PLCManvinder Singh BangaNED458£15.68£7,1811,388.20p-11.47-£823.04
06/02/1906/02/19BUYGSKGlaxosmithkline PLCManvinder Singh BangaNED481£14.95£7,1911,388.20p-7.14-£513.76
02/11/1831/10/18BUYGSKGlaxosmithkline PLCManvinder Singh BangaNED471£15.26£7,1871,388.20p-9.03-£648.58
25/07/1825/07/18BUYGSKGlaxosmithkline PLCManvinder Singh BangaNED462£15.57£7,1931,388.20p-10.84-£779.52
26/04/1825/04/18BUYGSKGlaxosmithkline PLCManvinder Singh BangaNED1,990£14.45£28,7561,388.20p-3.93-£1,130.82
26/04/1825/04/18BUYGSKGlaxosmithkline PLCManvinder Singh BangaNED1,990£14.45£28,7561,388.20p-3.93-£1,130.82
07/02/1807/02/18BUYGSKGlaxosmithkline PLCManvinder Singh BangaNED2,250£12.78£28,7551,388.20p8.62£2,479.50
25/10/1725/10/17BUYGSKGlaxosmithkline PLCManvinder Singh BangaNED1,894£15.18£28,7511,388.20p-8.55-£2,458.49
26/07/1725/07/17BUYGSKGlaxosmithkline PLCManvinder Singh BangaNED2,267£15.99£36,2491,388.20p-13.18-£4,778.51
27/04/1726/04/17BUYGSKGlaxosmithkline PLCManvinder Singh BangaNED1,816£15.83£28,7471,388.20p-12.31-£3,537.29
09/02/1708/02/17BUYGSKGlaxosmithkline PLCManvinder Singh BangaNED1,849£15.55£28,7521,388.20p-10.73-£3,084.18
Showing 1 to 20 of 28

Transaction types:

  • BUY - Buy
  • SELL - Sell
  • EXR - Exercise
  • SEXR - Sale Post-Exercise
  • DRI - Dividend Reinvestment
  • DRIP - Dividend Reinvestment Plan
  • AWD - Award
  • TIN - Transfer In
  • TOUT - Transfer Out
  • LOF - In Lieu of Fees/Salary
  • SI - Scrip Issue
  • PLAC - Placing
  • RIS - Rights Issue

Director positions:

  • CEO - Chief Executive Officer
  • CH - Chairman
  • MD - Managing Director
  • FD - Financial Director
  • NED - Non Executive Director
  • ED - Executive Director
  • RES - Resigned
  • D - Director / Unknown